Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association - 1 Feb 2015

Jeong Tae-Dong, Kim Seung Min, Kim Hyo Jin, Lee Woochang, Kwon Sun U, Min Won-Ki, Kang Dong-Wha, Chun Sail

Abstract excerpt

BACKGROUND: Early recurrent ischemic lesions detected on diffusion-weighted imaging (DWI) have been proposed as a surrogate marker for clinical recurrence. We hypothesized that cytochrome P450 2C19 (CYP2C19) genotype influences the incidence of early recurrence on DWI in acute stroke patients treated with clopidogrel. METHODS: We enrolled 76 Korean patients with acute ischemic stroke due to large artery...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Ischemia
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Diffusion Magnetic Resonance Imaging

Share to Platelet Aggregation Inhibitors

Share to Recurrence

Share to Stroke

Share to Ticlopidine

Source

Identifiers

PMID: 25529343
DOI: 10.1016/j.jstrokecerebrovasdis.2014.09.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel.PMID 25529343Read ↗

The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention.Semantic proximity Read ↗

Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.Semantic proximity Read ↗

[Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].Semantic proximity Read ↗

Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis.Semantic proximity Read ↗

The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis.Semantic proximity Read ↗

Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.Semantic proximity Read ↗

Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia.Semantic proximity Read ↗

Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis.Semantic proximity Read ↗

Genotype-guided ticagrelor/prasugrel versus clopidogrel therapy in stroke patients with CYP2C19 loss of function alleles: a systematic review and meta-analysis.Semantic proximity Read ↗

Impact of Cytochrome P450 2C19 Polymorphism on Ischemic Stroke PrognosisSemantic proximity Read ↗

Association between CYP2C19 gene polymorphisms and lipid metabolism in Chinese patients with ischemic stroke.Semantic proximity Read ↗

Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.